User:Mr. Ibrahem/Vaccinia immune globulin

Vaccinia immune globulin (VIG) is a medication used to treat severe complications of smallpox vaccination and monkeypox. With respect to complications, it is used for eczema vaccinatum, progressive vaccinia, severe generalized vaccinia, and vaccinia infections in those with certain skin conditions. It is given by gradual injection into a vein.

Common side effects include headache, dizziness, and nausea. Severe side effects may include allergic reactions, kidney problems, blood clotting, and transfusion-related acute lung injury. It is an immune globulin, specifically a gamma globulin, made from the blood of people immunized against smallpox.

Vaccinia immune globulin was approved for medical use in the United States in 2005. In the United States it is not commercially available though may be acquired from the Strategic National Stockpile. In Canada it is available from Public Health Agency of Canada.